SCHEDULE 13G

Company

Viridian Therapeutics, Inc.\DE

Filed

August 26, 2021

Accession Number

0001193125-21-257239

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →